Transforaminal Epidural Injection in Acute Sciatica
Recruiting
N/A
Interventional Study
Sciatica
Sciatica Due to Intervertebral Disc Disorder
Sciatic Radiculopathy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 142 (estimated)
- Sponsor
- C.L.A.Vleggeert-Lankamp · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Patients suffering from sciatica are treated conservatively for the first 8 weeks due to the favourable prognosis. This period is preferably extended up to 14-16 weeks after which patients may opt for surgery. However, patients may experience severe discomfort due to pain in the leg which can lead to decreased physical activity and socio-economic problems. An adequate therapy to alleviate symptoms…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Diagnosed with sciatica by GP
* NRS leg pain of 6 or more on a 10-point NRS scale
* Minimum duration of symptoms of 3 weeks and maximum duration of 8 weeks
Exclusion Criteria:
* Age under 18 years
* Condition preventing to receive transforaminal epidural injection
* Severe s…
Contacts